CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
to be used in future studies in study participants diagnosed with acute myeloid leukemia (AML), myelodysplastic s...
Phase 1, Phase 2
Pozuelo de Alarcón, Madrid, Spain and 33 other locations
The purpose of this study is to determine the recommended Phase 2 dose (RP2D) candidate(s) of bleximenib in combination with AML directed th...
Phase 1
Madrid, Spain and 33 other locations
Ziftomenib is an investigational drug in development for the treatment of patients with acute myeloid leukemia (AML...
Phase 3
Madrid, Madrid, Spain and 114 other locations
Cancer is a condition where cells in a specific part of the body grow and reproduce uncontrollably. Acute myeloid leukemia...
Phase 2, Phase 3
Majadahonda, Madrid, Spain and 16 other locations
treatment) or relapsed (disease has returned) acute myeloid leukemia (also known as R/R AML) and refractory or r...
Phase 1
Madrid, Spain and 5 other locations
or young adults with a certain kind of blood cancer (FLT3-ITD AML) might be able to join this study if it has come back after remission or i...
Phase 1, Phase 2
Madrid, Spain and 26 other locations
The purpose of this study is to assess if adding revumenib to standard chemotherapy improves outcomes in participants with AML with certain ...
Phase 3
Madrid, Spain and 82 other locations
\[GO\]) improves survival of children/adolescents/young adults with acute myeloid leukemia (AML) in 1st relapse w...
Phase 3
Madrid, Spain and 89 other locations
will be evaluated in patients with relapsed or refractory (R/R) acute myeloid leukemia (AML). The main study has ...
Phase 1, Phase 2
Madrid, Spain and 43 other locations
in combination with venetoclax for the treatment of newly diagnosed acute myeloid leukemia (AML) in adults who ar...
Phase 1, Phase 2
Madrid, Spain and 33 other locations
Clinical trials
Research sites
Resources
Legal